Viva Biotech Holdings(HK:1873)
HK$1.15-0.02 (-1.71%)
HK:1873
Viva Biotech Holdings financials statements
HK$1.15
At close:-0.02 (-1.71%)
Want to see HK:1873 full AI Analyst Report?
Viva Biotech Holdings (1873) Financial Statements
4 Followers
Viva Biotech Holdings Financial Overview
Viva Biotech Holdings's market cap is currently ¥2.43B. The company's EPS TTM is ¥0.08; its P/E ratio is 12.11; and it has a dividend yield of 0.27%. Viva Biotech Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.73B | ¥ 1.99B | ¥ 2.16B | ¥ 2.38B | ¥ 2.10B |
| Gross Profit | ¥ 655.56M | ¥ 687.40M | ¥ 738.43M | ¥ 815.68M | ¥ 650.98M |
| Operating Income | ¥ 193.25M | ¥ 229.67M | ¥ 192.68M | ¥ 269.35M | ¥ 236.90M |
| EBITDA | ¥ 404.30M | ¥ 443.53M | ¥ 403.90M | ¥ 451.35M | ¥ 390.06M |
| Net Income | ¥ 219.76M | ¥ 167.29M | ¥ -116.11M | ¥ -528.48M | ¥ 287.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.13B | ¥ 941.58M | ¥ 1.04B | ¥ 678.57M | ¥ 800.95M |
| Total Assets | ¥ 7.20B | ¥ 7.05B | ¥ 7.45B | ¥ 7.92B | ¥ 8.04B |
| Total Debt | ¥ 1.33B | ¥ 1.28B | ¥ 1.90B | ¥ 2.82B | ¥ 2.65B |
| Net Debt | ¥ 221.91M | ¥ 342.47M | ¥ 866.89M | ¥ 2.14B | ¥ 1.85B |
| Total Liabilities | ¥ 3.19B | ¥ 3.23B | ¥ 3.76B | ¥ 4.32B | ¥ 4.13B |
| Stockholders' Equity | ¥ 4.00B | ¥ 3.80B | ¥ 3.69B | ¥ 3.60B | ¥ 3.91B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 88.02M | ¥ 182.32M | ¥ 195.57M | ¥ 136.72M | ¥ -487.35M |
| Operating Cash Flow | ¥ 206.04M | ¥ 373.99M | ¥ 383.40M | ¥ 386.05M | ¥ 77.83M |
| Investing Cash Flow | ¥ -93.76M | ¥ 185.90M | ¥ 439.17M | ¥ -372.80M | ¥ -868.84M |
| Financing Cash Flow | ¥ 36.61M | ¥ -657.76M | ¥ -429.50M | ¥ -143.20M | ¥ -653.16M |
Currency in CNY

